The number of deaths linked to superbugs that do not respond to frontline antibiotics increased by 17% in England last year, according to official figures that raise concerns about the ongoing increase in antimicrobial resistance.
The figures, released by the UK Health Security Agency, also revealed a large rise in private prescriptions for antibiotics, with 22% dispensed through the private sector in 2024.
The increase in private prescribing is partly explained by the Pharmacy First scheme, a flagship policy of Rishi Sunak’s government that allows patients to be prescribed antibiotics for common illnesses without seeing a GP, raising questions about whether the shift in prescribing patterns risks contributing to the rise in resistance.
“Antibiotic resistance is one of the greatest health threats we face,” said the UKHSA’s chief executive, Prof Susan Hopkins. “More people than ever are acquiring infections that cannot be effectively treated by antibiotics. This puts them at greater risk of serious illness and even death, with our poorest communities hit the hardest.”
The emergence of drug-resistant strains is an inevitable consequence of natural selection. Whenever the drugs are used they wipe out some bugs, but any survivors multiply and are transmitted.
Limiting the use of antibiotics to when they are most needed is one of the most effective ways of combatting the spread of resistance, which it has been predicted could cause as many as 10 million deaths a year globally by 2050.
The latest surveillance data found that the number of antibiotic-resistant infections in 2024 equated to an average of nearly 400 newly reported cases a week.
Source: The Guardian, 13 November 2025
Recommended Comments
Create an account or sign in to comment